Strong fundamentals

This stock has some great fundamentals behind it.

It has one of the lowest PE of 10 compared to similar AC providers like Japara and Regis (17 and 22 respectively)
Great assets in strategic locations
$90mn profit guidance with $540mn market cap
Established network and decent occupancy rates
Lower yet continued Medicare funding - remember cash flow if king and this company has it.
Age care funding cuts have been largely discounted in this market price

Compare this with Pathology companies performance when similar 'Pathology fee cuts' took place back in February 2009. Most pathology companies bounced back after some smart internal restructuring within a matter of months and are now nearly three times the price back then.

Great value opportunity here, IMHO!